Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

DNA damage repair

  • Open Access
    A Gene Expression Signature that Predicts Gastric Cancer Sensitivity to PARP Inhibitor Therapy
    KEIICHI FUJIYA, MASAKUNI SERIZAWA, KEIICHI OHSHIMA, RINA UMEHARA, YUKO WATANABE, TAKESHI NAGASHIMA, ETSURO BANDO, KENICHI URAKAMI, YASUTO AKIYAMA, YASUHIRO TSUBOSA, TAKASHI SUGINO, KEN YAMAGUCHI and MASANORI TERASHIMA
    Anticancer Research November 2024, 44 (11) 4779-4788; DOI: https://doi.org/10.21873/anticanres.17304
  • You have access
    Dual Biomarker Combining DNA Damage Repair Gene Mutations and PD-L1 Expression for Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    HYERA KIM, DONG HYUN LIM, YONG SHIK KWON, MI AE KIM and KEON UK PARK
    Anticancer Research May 2023, 43 (5) 2343-2349; DOI: https://doi.org/10.21873/anticanres.16399
  • You have access
    Determination of Clonogenic Radiosensitivity of HeLa Cells in Early and Late G1 Phases
    KOHKI TOHYAMA, ATSUSHI KAIDA and MASAHIKO MIURA
    Anticancer Research November 2022, 42 (11) 5407-5413; DOI: https://doi.org/10.21873/anticanres.16045
  • You have access
    Anti-leukemic Activity of AIU2008 in FLT3-ITD-positive Acute Myeloid Leukemia
    HYO JEONG KIM, HWANI RYU, HYUN-KYUNG CHOI, JIE-YOUNG SONG, SANG-GU HWANG and JIYEON AHN
    Anticancer Research February 2021, 41 (2) 731-737; DOI: https://doi.org/10.21873/anticanres.14824
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire